ClinicalTrials.govpublic full text
Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis
multiple myeloma, refractory to standard treatment, multiple myeloma, relapsed, light chain amyloidosis, relapsed/refractory multiple myeloma, light-chain amyloidosis, b-cell maturation antigen (bcma), autologous car-t, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 911357
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.